Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 1/20 | 0.60 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 3/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.51 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.51 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3292238 | 0.98 | PDCD1 (0.62) | PDCD1CD274RAB9ANPC1CTDSP1 | |
| Biphenyl SCHEMBL7862554 | 0.95 | F2 (0.61) | PDCD1CD274RAB9ANPC1CTDSP1 | |
| SCHEMBL19666759 | 0.94 | MAPT (0.62) | PDCD1CD274RAB9ANPC1CTDSP1 | |
| Ethyne SCHEMBL28750829 | 0.91 | LMNA (0.56) | PDCD1CD274RAB9ANPC1CTDSP1 | |
| SCHEMBL8717537 | 0.91 | LMNA (0.67) | SMN1; SMN2KDM4ELMNAF2MAPT | |
| SCHEMBL52413 | 0.88 | LMNA (0.70) | SMN1; SMN2LMNAF2MAPTL3MBTL1 | |
| Benzene SCHEMBL27793442 | 0.88 | LMNA (0.70) | SMN1; SMN2LMNAF2MAPTL3MBTL1 | |
| Hydrogen Peroxide SCHEMBL27952375 | 0.88 | LMNA (0.70) | SMN1; SMN2LMNAF2MAPTL3MBTL1 | |
| SCHEMBL28073554 | 0.88 | CYP1A2 (0.58) | PDCD1CD274SMN1; SMN2KDM4EMAPT | |
| Biphenyl SCHEMBL10761998 | 0.87 | ESR1 (0.59) | PDCD1CD274RAB9ANPC1CTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110627832-A | Preparation method for synthesizing tenofovir alafenamide by oxidation method | 江西农业大学 | 2019-12-31 | — | — | CN | claimed |
| CN-105218372-A | (4-Phenylbenzoyl) benzoic ether and the purposes as light trigger thereof | INSIGHT HIGH TECHNOLOGY BEIJING CO LTD | 2016-01-06 | — | — | CN | claimed |
| CN-103429680-B | Radiation curable compositions | ALLNEX Belgium SA | 2015-06-17 | — | — | CN | claimed |
| CN-103443215-A | Radiation curable compositions | ALLNEX Belgium SA | 2013-12-11 | — | — | CN | claimed |
| CN-103429680-A | Radiation curable compositions | ALLNEX Belgium SA | 2013-12-04 | — | — | CN | claimed |
| EP-4437048-B1 | ENERGY CURABLE INK, COATING AND PRIMER COMPOSITIONS CONTAINING HIGHLY ALKOXYLATED GLYCEROL ACRYLATES FOR RETORT PACKAGING APPLICATIONS | SUN CHEMICAL BV (NL) | 2026-02-25 | — | — | EP | disclosed |
| CN-119191950-A | Asymmetric diaryl ketone compound and synthetic method thereof | 海南大学 | 2024-12-27 | — | — | CN | disclosed |
| EP-3134379-B1 | LIQUID ARYLBENZOYL BENZOIC ACID ESTER DERIVATIVES FOR ENERGY CURABLE COMPOSITIONS | SUN CHEMICAL BV (NL) | 2024-08-28 | — | — | EP | disclosed |
| CN-111936136-B | Novel imidazopyrimidine compounds and uses thereof | 儿童医学中心公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-110627832-A | Preparation method for synthesizing tenofovir alafenamide by oxidation method | 江西农业大学 | 2019-12-31 | — | — | CN | disclosed |
| US-9938231-B2 | Liquid arylbenzoyl benzoic acid ester derivatives for energy curable compositions | SUN CHEMICAL CORPORATION (US) | 2018-04-10 | — | — | US | disclosed |
| US-9938231-B2 | Liquid arylbenzoyl benzoic acid ester derivatives for energy curable compositions | SUN CHEMICAL CORPORATION (US) | 2018-04-10 | — | — | US | disclosed |
| CN-103429680-A | Radiation curable compositions | ALLNEX Belgium SA | 2013-12-04 | — | — | CN | disclosed |
| CN-103429679-A | Radiation curable compositions | CYTEC SURFACE SPECIALTIES SA | 2013-12-04 | — | — | CN | disclosed |
| US-7727434-B2 | Membranes and methods of treating membranes | GENERAL ELECTRIC COMPANY (US) | 2010-06-01 | — | — | US | disclosed |
| US-20070039874-A1 | Membranes and methods of treating membranes | GENERAL ELECTRIC COMPANY | 2007-02-22 | — | — | US | disclosed |
| US-20030181742-A1 | Process for the preparation of pregnane derivatives | KURARAY CO., LTD. (JP) | 2003-09-25 | — | — | US | disclosed |
| EP-1325928-A1 | PROCESS FOR THE PREPARATION OF PREGNANE DERIVATIVES | Kuraray Co., Ltd. (JP) | 2003-07-09 | — | — | EP | disclosed |
| EP-0507576-A1 | Polypropylene-based resin compositions | TOSOH CORPORATION (JP) | 1992-10-07 | — | — | EP | disclosed |
| US-4988460-A | HYDROGEN BONDED ADDITION POLYMERS, POLYCARBONATES, POLYESTERS, OR POLYAMIDES, AROMATIC ESTER DERIVATIVES AS LIQUID CRYSTALS | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1991-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181742-A1 | Process for the preparation of pregnane derivatives | CYP21A2, CYP11B2, CYP17A1 | PDCD1 3509/4885CD274 4257/4885RAB9A 4281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.